Tg Therapeutics reported $36.45M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 14.33B 1.71B
Ardelyx ARDX:US USD 51.95M 3.25M
Arrowhead Research ARWR:US USD 138.85M 10.64M
Bayer BAYN:GR EUR 33.17B 471M
Biogen BIIB:US USD 3.93B 1.09B
Corcept Therapeutics CORT:US USD 53.07M 4.01M
Curis CRIS:US USD 13.74M 1.59M
Dynavax Technologies DVAX:US USD 244.08M 101.12M
Gilead Sciences GILD:US USD 10.42B 1.2B
Infinity Pharmaceuticals INFI:US USD 14.2M 139K
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Novartis NOVN:VX USD 28.16B 514M
Novavax NVAX:US USD 1.67B 488.28M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Puma Biotechnology PBYI:US USD 59.99M 3.15M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Spectrum Pharmaceuticals SPPI:US USD 49.62M 8.58M
Tg Therapeutics TGTX:US USD 36.45M 6.88M
Verastem VSTM:US USD 21.87M 1.78M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
Ziopharm Oncology ZIOP:US USD 32.87M 6.09M